--- title: Racial Disparities in the Burden of End-Stage Renal Disease due to Diabetes among Medicare Beneficiaries description: July 2018 | Namino M. Glantz; Ian Duncan; Tamim Ahmed; David Kerr --- Publication # Racial Disparities in the Burden of End-Stage Renal Disease due to Diabetes among Medicare Beneficiaries [ Arbital Health ](https://arbitalhealth.com/blog/author/arbital-health) Jul 1, 2018 [mailto:?subject=Check%20out%20https://arbitalhealth.com/blog/racial-disparities-in-the-burden-of-end-stage-renal-disease-due-to-diabetes-among-medicare-beneficiaries&utm_medium=social&utm_source=email%20&body=Check%20out%20https://arbitalhealth.com/blog/racial-disparities-in-the-burden-of-end-stage-renal-disease-due-to-diabetes-among-medicare-beneficiaries&utm_medium=social&utm_source=email](mailto:?subject=Check%20out%20https://arbitalhealth.com/blog/racial-disparities-in-the-burden-of-end-stage-renal-disease-due-to-diabetes-among-medicare-beneficiaries&utm_medium=social&utm_source=email%20&body=Check%20out%20https://arbitalhealth.com/blog/racial-disparities-in-the-burden-of-end-stage-renal-disease-due-to-diabetes-among-medicare-beneficiaries&utm_medium=social&utm_source=email) [Publication](https://arbitalhealth.com/blog/tag/publication) Published: July 1, 2018 Publisher: American Diabetes Association By: Namino M. Glantz; Ian Duncan; Tamim Ahmed; David Kerr   Diabetes disproportionately impacts minority populations in the United States. In particular, Hispanics are almost twice as likely as non-Hispanic whites to be diagnosed with diabetes and have higher rates of end-stage renal disease (ESRD) due to diabetes. We analyzed data from the Medicare 5% sample file by race/ethnicity for type 1 (T1D) and type 2 diabetes (T2D) to determine the economic burden of ESRD. For the years 2012-13 we identified 1,397,933 enrollees from the publicly-available Medicare 5% sample > 65 years without Medicare Advantage coverage (HMO). The prevalence of T1D was 2.0% and 21.9% for T2D. ESRD affected 5.4% of the T1D and 1.9% of T2D populations. Rates of ESRD were significantly higher for other races for both T1D and T2D compared to whites. Comparing costs, allowed amount (claims less discounts/ineligible charges) for treating ESRD was higher for T1D Hispanics than T1D whites ($8,946 vs. $8,332 per member/month, P<0.001). In contrast to other races, T2D Hispanics with ESRD were not more costly than whites ($6,634 vs. $6,542). Similar results were seen for net paid costs taking into account cost-sharing. Average cost-sharing for all patients with ESRD was $730 (no diabetes), $1,177 (T1D) and $939 (T2D) per member/month respectively. In conclusion, the burden of ESRD due to T1D and T2D and the associated cost for T1D with ESRD were higher for Hispanics than for white Medicare enrollees.  [ Read Full Publication ](https://diabetesjournals.org/diabetes/article/67/Supplement_1/1281-P/55135)   ### View More News & Insights from the Arbital Health Team: Publication ### [Racial and Ethnic Disparities in the Burden and Cost of Diabetes for US Medicare Beneficiaries](https://arbitalhealth.com/blog/racial-and-ethnic-disparities-in-the-burden-and-cost-of-diabetes-for-us-medicare-beneficiaries) Arbital Health May 15, 2019 Publication ### [Patient Post-discharge Transitions and Inpatient Readmissions Impose Costly Burdens for Employers and Carriers](https://arbitalhealth.com/blog/patient-post-discharge-transitions-and-inpatient-readmissions-impose-costly-burdens-for-employers-and-carriers) Arbital Health Dec 3, 2021 Publication ### [Comparing Model Error Between a Standard Risk Adjustment Model and a Disease-Specific Risk Adjustment Model](https://arbitalhealth.com/blog/comparing-model-error-between-a-standard-risk-adjustment-model-and-a-disease-specific-risk-adjustment-model) Arbital Health Dec 1, 2020 ### Sign-Up for Arbital Health Email Updates Unlock a wealth of valuable insights and stay ahead of the curve with Arbital Health's exclusive email updates. Join our community of forward-thinkers and industry leaders to receive the latest news, upcoming webinar alerts, and crucial developments in VBC strategies straight to your inbox. Don't miss out on the opportunity to stay informed, connected, and empowered in the ever-evolving landscape of healthcare. | SOLUTIONS | WHO WE SERVE | WHO WE ARE | RESOURCES | | --- | --- | --- | --- | | [Arbital Platform](https://arbitalhealth.com/adjudication-platform) [Actuarial Services](https://arbitalhealth.com/actuarial-services) [Arbital AI](https://arbitalhealth.com/merlin-ai) [Arbital ATLAS](https://arbitalhealth.com/atlas) [Arbital Flex](https://arbitalhealth.com/flex) | [Providers](https://arbitalhealth.com/who-we-serve) [Payers](https://arbitalhealth.com/who-we-serve#Payers) [Value-Based Care Enablers](https://arbitalhealth.com/who-we-serve#RiskBearingEntities) [Employers](https://arbitalhealth.com/who-we-serve#Employers) | [About Us](https://arbitalhealth.com/about-us) [Our Team](https://arbitalhealth.com/our-team) [Careers](https://arbitalhealth.com/careers) | [All Content](https://arbitalhealth.com/blog) [Blog](https://arbitalhealth.com/blog/tag/blog#blog) [Press Releases](https://arbitalhealth.com/blog/tag/press-release#blog) [Talks](https://arbitalhealth.com/blog/tag/talks#blog) [Events](https://arbitalhealth.com/blog/tag/events#blog) **[Privacy Policy](https://arbitalhealth.com/privacy-policy)** |   STAY IN TOUCH Join a network of innovators shaping the future of healthcare. Receive timely updates, exclusive event invitations, and expert insights on value-based care strategies. ![SUBSCRIBE TO OUR NEWSLETTER](https://no-cache.hubspot.com/cta/default/44728686/interactive-193352706174.png) By submitting, I give Arbital Health permission to store and process your personal information so we can provide you with the content you’ve requested. ![Arbital_Logo_Full_Color_KO_rgb_022124](https://arbitalhealth.com/hubfs/Arbital_Logo_Full_Color_KO_rgb_022124.png) 98 Battery Street, Suite 400, San Francisco, CA    94111 (415) 226-9393 © Arbital Health. All Rights Reserved 2025. ![](https://px.ads.linkedin.com/collect/?pid=6309914&fmt=gif) ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Arbital Health", "url" : "https://arbitalhealth.com/blog/author/arbital-health" }, "dateModified" : "2025-02-06T18:13:57.126Z", "datePublished" : "2018-07-01T07:00:00.000Z", "headline" : "Racial Disparities in the Burden of End-Stage Renal Disease due to Diabetes among Medicare Beneficiaries", "mainEntityOfPage" : { "@id" : "https://arbitalhealth.com/blog/racial-disparities-in-the-burden-of-end-stage-renal-disease-due-to-diabetes-among-medicare-beneficiaries", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://arbitalhealth.com/hubfs/Branding%20Assets/Arbital_Logo_020524-1.png" }, "name" : "Arbital Health" } } ```